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Michel de Lorgeril* and Patricia SalenAbstract
In addition to genetic predisposition and sex hormone exposure, physical activity and a healthy diet play important
roles in breast cancer (BC). Increased intake of omega-3 fatty acids (n-3) associated with decreased omega-6 (n-6),
resulting in a higher n-3/n-6 ratio compared with the western diet, are inversely associated with BC risk, as shown
by Yang et al. in their meta-analysis in BMC Cancer. High consumption of polyphenols and organic foods increase
the n-3/n-6 ratio, and in turn may decrease BC risk. Intake of high fiber foods and foods with low glycemic index
decreases insulin resistance and diabetes risk, and in turn may decrease BC risk. The modernized Mediterranean diet
is an effective strategy for combining these recommendations, and this dietary pattern reduces overall cancer risk
and specifically BC risk. High-risk women should also eliminate environmental endocrine disruptors, including those
from foods. Drugs that decrease the n-3/n-6 ratio or that are suspected of increasing BC or diabetes risk should be
used with great caution by high-risk women and women wishing to decrease their BC risk.
Please see related article: http://www.biomedcentral.com/1471-2407/14/105/abstract.
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Mediterranean dietIntroduction
Breast cancer (BC) remains one of the commonest can-
cers – one in eight women will be diagnosed with BC
in her lifetime [1] – and a leading cause of death from
cancer. However, it remains a significant scientific and
medical challenge. One of the crucial gaps identified is
how to implement a sustainable preventive lifestyle
strategy [2]. Both risk factors and protective factors
must be considered. Some risk factors, such as genetic
predisposition, cannot be modified, whereas others
(unhealthy diet, sedentary lifestyle) can be avoided.
Increasing protective factors may be crucial for women at
high risk (as evaluated by the National Cancer Institute’s
(NCI’s) BC Risk Assessment Tool [3]) and in preventing
recurrence and improving survival after BC diagnosis.
Decreasing the length of time a woman’s breast tissue is
exposed to estrogens may help prevent BC [1-3], although* Correspondence: michel.delorgeril@ujf-grenoble.fr
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article, unless otherwise stated.the main ways of achieving this (first pregnancy before the
age of 20 years, breast feeding, late menstruation and early
menopause) are difficult to control.
There are strong links between environmental/lifestyle
factors and BC, suggesting that modifying these factors
may result in decreasing BC risk, although there has
been no randomized trial that clearly demonstrated this. As
changing these factors has been shown also to definitely
reduce the risk of fatal diseases, notably cardiovascular
diseases in randomized trials, it is reasonable to propose
these changes to high-risk women and to women who
wish to reduce their BC risk.
For instance, dietary fats have been extensively studied in
the prevention of BC [4]. Neither animal fat nor a low-fat
diet has been linked to BC risk, whereas marine omega-3
fatty acids (n-3) may be protective [4]. In a meta-analysis of
21 independent prospective cohort studies, Zheng et al.
found a significant reduction of BC risk with marine n-3
[5]. However, this meta-analysis highlights the difficulties in
assessing the effects of specific dietary fats on BC risk. InCentral Ltd. This is an Open Access article distributed under the terms of the
/creativecommons.org/licenses/by/4.0), which permits unrestricted use,
, provided the original work is properly credited. The Creative Commons Public
mons.org/publicdomain/zero/1.0/) applies to the data made available in this
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ciations between marine n-3 and BC risk were significant
only in post-menopausal women, were stronger in East
Asian populations compared with western populations
and were more evident without adjustment for body
mass index (BMI). This suggests that marine n-3 may
influence BC risk partly through an effect on BMI or
related factors (insulin or adipokines), whereas the im-
portance of BMI on BC risk during the pre-menopausal
and post-menopausal periods is still a matter of controversy
[6]. The East Asian population issue suggests that other
foods/nutrients and related factors may be involved. For
instance, omega-6 fatty acids (n-6) may play a role in BC
risk [7]. It has long been suspected that n-6 increase the
risk of cancers, and this has been confirmed in controlled
trials in which n-6 intakes were modified. In the Los
Angeles Trial, there were more cancers in the experimen-
tal group with high n-6 intake, whereas in the Lyon Diet
Heart Study, there were fewer cancers in the group with
low n-6 [8,9]. Thus, when analyzing the associations be-
tween n-3 and BC risk, it is crucial that n-6 is included in
the analyses, as Yang et al. did in their recent study pub-
lished in BMC Cancer [10].
Breast cancer risk and n-3/n-6 ratios
Yang et al. used the ratio of n-3/n-6 in a meta-analysis
comprising 274,135 women with a total of 8,331 BC events
from 11 independent prospective studies [10]. Women with
a higher n-3/n-6 ratio had a significantly lower risk of BC:
pooled RR 0.90, 95% CI 0.82 to 0.99. When the authors
analyzed only dietary intake, they found a 6% reduction in
BC risk per one-tenth increment of the n-3/n-6 ratio. The
association between the blood phospholipid n-3/n-6 ratio
and BC risk (in four studies only) did not reach statistical
significance. The lack of a significant relationship between
BC risk and blood n-3/n-6 ratio is not unexpected, because
n-3 and n-6 measured in phospholipids do not accurately
reflect dietary intake. Several factors (discussed in the next
paragraph) interfere with the levels of both n-3 and n-6 in
each class of phospholipids. In addition, the fatty acid com-
position of each phospholipid is not identical: it differs in
serum, red cell membranes, and mitochondria, for example,
and these various phospholipids have a different physiology
and a different effect (if any) on cancers [7]. There are
nonetheless correlations between dietary n-6 and n-3 and
the corresponding fatty acids in blood and cells, and it is
not illogical to pool data from diet and blood when analyz-
ing relationships with BC risk. It is, however, crucial to bear
these differences in mind when interpreting the results, and
potential confounders should be included in the analyses if
possible; that is, if they have been recorded in a timely and
accurate fashion. In the next section, we highlight some
lifestyle, environmental, and pharmacological factors that
influence n-3/n-6 ratios, and examine their relationshipswith BC risk. In most studies included in the meta-analysis
by Yang et al., these factors were not measured, which
is likely to have weakened the associations between n-3/n-6
ratio and BC risk.
Factors influencing n-3/n-6 ratios and BC risk
Among the main risk factors of BC, estrogen exposure,
lack of physical exercise and being overweight are well
known [1-3].
Studies support an association between endogenous
sex hormone levels and BC risk for post-menopausal
women, whereas the association is less clear for pre-
menopausal women [11]. One possible explanation is
that the high estrogen levels present before menopause
increase blood marine n-3 [12], which in turn may
partly counteract the effect of estrogens, as marine n-3
are protective [5,7,10].
Besides increased intake of n-3 and decreased intake
of n-6 through consumption of foods rich in n-3 and poor
in n-6 [7-9], other substances are known to affect the n-3/
n-6 ratio. The endogenous synthesis of marine n-3 from
their plant substrate alpha-linolenic acid (ALA) is stimu-
lated by the plant pigment polyphenols found in purple
fruits such as grapes (and wines), plums, and blueberries
[13-15]. Polyphenol flavonoids increase marine n-3 by
30% without altering n-6 levels, resulting in a significant
increase in the n-3/n-6 ratio. As expected from the above
data, flavonoids are associated with a decreased BC risk
[16]. These data are encouraging, as it is difficult to ac-
curately determine the intake of each flavonoid, and this
probably weakens the association between specific fla-
vonoids and BC risk. In addition, the bioavailability and
biological effect of flavonoids are dependent on many
factors, including the gut microbiota [17], which again
is likely to weaken the associations. A typical example of
such complexity is provided by the soy flavonoids.
Soy isoflavones, a major class of phytoestrogens, may
reduce BC risk, but epidemiologic studies have yielded
inconsistent results [18]. A meta-analysis suggests that
protection is only observed in studies conducted in East
Asian and not in western populations [18], suggesting
that protection may require that women consume the
high levels of soy typical of East Asian diets. In addition,
the food source of isoflavones, timing of exposure to
isoflavones (starting at or not before adolescence), the
woman’s menopausal status, and the ability of the gut
microbiota to transform isoflavones into equol probably
modify the association between soy isoflavones and BC
risk. Equol is more biologically active (that is, more anti-
estrogenic) than dietary isoflavones, but only about 30% of
women in the USA and Australia are equol producers [19].
Finally, the small studies examining whether equol expos-
ure is associated with BC risk have produced inconsistent
results [20]. Other phytoestrogens more characteristic
Table 1 How to reduce breast cancer risk and improve
survival after diagnosis
Item Recommendations
Exposure to sex steroids Decrease
Physical activity Adopt optimal level1
Modernized Mediterranean diet2 Full adherence
Plant and marine n-3 Increase3
Plant and animal n-6 Decrease3
Polyphenols Increase3
Fiber Increase3
High GI foods Decrease3
Alcohol (no more than 1 drink/day) Preferably wine
Organic foods (plant and animal sources) May be beneficial
Exposure to endocrine disruptors Decrease where possible
Insulin resistance and diabetic risk Decrease4
Age-associated weight gain Limit4
Drugs
Cholesterol-lowering statins Use caution
Drugs suspected to increased BC risk Use caution
Drugs suspected to increased insulin
resistance and diabetic risk
Use caution
BC, breast cancer; GI, glycemic index.
1Tailored to the capacity of each individual.
2Consider an alternative healthy diet in specific populations; Okinawan diet for
East Asians for instance.
3Compared with a western-style diet.
4By adhering to the modernized Mediterranean diet (see text).
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in seeds, grains, fruits, and vegetables. High dietary lignans
or high exposure to enterolignans, the metabolites resulting
from transformation by the gut microbiota, are associated
with lower BC risk and better survival in post-menopausal
BC [21,22]. This is not unexpected, as we have shown in
rats that lignans increase blood n-3 without affecting n-6,
resulting in a higher n-3/n-6 ratio [7,13].
Another crucial point is the fact that organic plant foods
contain more polyphenols than similar conventional foods
[23-26]. Organic animal fat also - for instance, milk and
milk products - do have a higher n-3/n-6 ratio than con-
ventional products [27-29]. Organic-fed animals mainly
consume non-contaminated fresh grass with a high poly-
phenol content, rather than polyphenol-poor concentrates
potentially contaminated with pesticides, and this may
partly explain the favorable n-3/n-6 ratio [30,31].
Regarding food contaminants, recent studies have
shown a strong association between estrogenic PCBs
(polychlorobiphenyls) congeners and BC risk [32]. In
this context, it is crucial to identify ’hidden’ groups of
women whose occupational exposure to carcinogens is
underrepresented in epidemiological studies. Studies
have recently shown significant associations between
BC risk and endocrine disruptors in women with spe-
cific professional exposure [33]. Endocrine disruptors
(particularly phthalates) increase insulin resistance,
and the risk of diabetes and obesity [34], all of which
increase BC risk [1-3].
Other commonly encountered substances that poten-
tially influence both n-3/n-6 ratio and BC risk are the
cholesterol-lowering statins. Statins decrease n-3/n-6
ratio [35], increase insulin resistance and diabetes risk
[36], lower cholesterol, and are toxic to mitochondria [37].
Whether or not statins, by modifications of the above pro-
cesses [35-38], are involved in increased BC risk, remains
an area of controversy. Therefore, when weighing up
the benefits and potential risks of statins, caution should
be applied prior to prescription. Following the same line
of reasoning, high-risk women should do everything they
can to reduce their risk of insulin resistance, metabolic syn-
drome and diabetes [1-3]. Beside optimal physical activity,
which is a well-known strategy for decreasing both diabetes
and BC [1-3] risks, high fiber intake, high flavonoids, and
high n-3 are all inversely associated with diabetes risk.
Accordingly, fiber intake, flavonoids [16], and n-3 [5,7,10]
are inversely associated with BC risk. Finally, consumption
of foods with a lower glycemic impact – that is, a low gly-
cemic index (GI) – is associated with a lower incidence of
diabetes and a lower BC risk [1-3].
These data are highly consistent, and the combination of
high fiber, high n-3/n-6 ratio, high polyphenols, and low-GI
foods represents what many experts call a healthy dietary
pattern – for instance, the Mediterranean diet – which hasbeen associated with a lower BC risk and better survival for
women with early-stage BC.
Reducing BC risk
In summary (see Table 1), the accumulated evidence shows
that in addition to genetic predisposition and estrogen
exposure, a number of lifestyle, environmental, and pharma-
cological factors play an important role in BC risk and
BC survival. Optimal physical activity decreases insulin
resistance, diabetes risk, and the risk and progression
of BC [39]. Adhering to a healthy dietary pattern – a
modernized Mediterranean diet [40], or a similar healthy
diet adapted to specific populations, such as the Okinawan
diet in East Asians [41] – has been shown to be effective.
Emphasis should be given to increasing plant and animal
(including marine) n-3, and decreasing plant and animal
n-6. High polyphenol consumption, in particular of fla-
vonoids, which increase the synthesis of marine n-3 and
result in a higher n-3/n-6 ratio, is associated with lower
BC risk. To reduce insulin resistance and diabetes, which
are associated with an increased BC risk, women should
increase their consumption of n-3 and fiber and favor
low-GI foods. In addition, organic foods have been shown
to contain more polyphenols and have a higher n-3/n-6
ratio than non-organic foods. As a higher n-3/n-6 ratio
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of organic foods may be beneficial. Care must be taken
to reduce (professional and non-professional) exposure
to environmental chemical contaminants. Drugs that
decrease the n-3/n-6 ratio, and/or increase insulin re-
sistance and diabetic risk (in particular statins) should
be taken with caution.
Conclusions
National and international cancer associations regularly
release anti-cancer guidelines. For instance, every five
years the American Cancer Society publishes its Nutrition
and Physical Activity Guidelines, which reflect current
scientific evidence and focus on recommendations for
individual choices regarding diet and physical activity
patterns [42]. These Guidelines state: ‘for people who
do not use tobacco, the most important modifiable
determinants of cancer risk are weight control, dietary
choices, and levels of physical activity’ and ‘although
genetic susceptibility influences the risk of cancer, most
of the variation in cancer risk across populations and
among individuals is due to factors that are not inherited’.
Regarding BC specifically, the Guidelines state, ‘the best
advice to reduce the risk of breast cancer is to engage in
regular, intentional physical activity; to minimize lifetime
weight gain through the combination of caloric restriction
(in part by consuming a diet rich in vegetables and fruits)
and regular physical activity; and to avoid or limit intake
of alcoholic beverages’ [42].
We agree wholeheartedly with this advice. However,
we feel it is time to go further and to be more specific.
A specific healthy dietary pattern such as the modernized
Mediterranean diet, and not simply “consuming a diet rich
in vegetables and fruits”, should be adopted to decrease
BC risk. This is also an effective way of maintaining a
healthy weight, and preventing diabetes and cardiovascular
disease. The focus must be on the n-3/n-6 ratio and poly-
phenols. Organic foods are shown to contain higher levels
of these than non-organic foods, and so may be beneficial.
Great care should be taken when using drugs that poten-
tially increase BC risk. This also applies to BC survivors to
prevent recurrence and improve survival [43].
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